QUINCE THERAPEUTICS INC (QNCX) Top Institutional Shareholders

QUINCE THERAPEUTICS INC (QNCX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $2.30M in QNCX holdings during the latest filing period.

Union Square Park Capital Management, Llc is currently the largest disclosed institutional shareholder of QNCX tracked by InsiderSet, reporting ownership valued at approximately $752,899 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $202,945.638, representing an estimated loss of -73.04% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 96% of the total disclosed QNCX value among the investors covered in this analysis. Major shareholders include Union Square Park Capital Management, Llc, Woodline Partners Lp, Independent Financial Group, Llc, and several other long-term asset managers with concentrated positions in QUINCE THERAPEUTICS INC (QNCX).

This page ranks the largest institutional QNCX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

38

Total Reported Value

$2.30M

Largest Holder

Union Square Park Capital Management, Llc

Largest Position

$752,899

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

79

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Union Square Park Capital Management, Llc0.61%224,746$752,899$202,946-$549,953-73.04%
Woodline Partners Lp0.00%5,200,000$527,280$4,695,600+$4,168,320+790.53%
Independent Financial Group, Llc0.00%3,175$291,021$2,867-$288,154-99.01%
Millennium Management Llc0.00%2,503,717$253,877$2,260,856+$2,006,979+790.53%
Shay Capital Llc0.03%1,772,909$179,773$1,600,937+$1,421,164+790.53%
Ieq Capital, Llc0.00%600,105$60,851$541,895+$481,044+790.53%
Blackrock, Inc.0.00%473,259$47,989$427,353+$379,364+790.52%
Vanguard Capital Management Llc0.00%461,477$46,609$416,714+$370,105+794.06%
State Street Corp0.00%248,011$25,148$223,954+$198,806+790.54%
Vanguard Fiduciary Trust Co0.00%232,326$23,465$209,790+$186,325+794.06%
Susquehanna International Group, Llp0.00%172,640$17,506$155,894+$138,388+790.52%
Simplex Trading, Llc0.00%154,093$15,563$139,146+$123,583+794.08%
Vanguard Personalized Indexing Management, Llc0.00%132,661$13,452$119,793+$106,341+790.52%
Two Sigma Investments, Lp0.00%71,223$7,222$64,314+$57,092+790.53%
Northern Trust Corp0.00%65,931$6,685$59,536+$52,851+790.59%
Intellectus Partners, Llc0.00%53,312$5,406$48,141+$42,735+790.51%
Adar1 Capital Management, Llc0.00%50,100$5,080$45,240+$40,160+790.56%
Xtx Topco Ltd0.00%48,812$4,950$44,077+$39,127+790.45%
Nordwand Advisors, Llc0.00%20,000$2,028$18,060+$16,032+790.53%
Scharf Investments, Llc0.00%19,461$1,973$17,573+$15,600+790.69%
Vanguard Global Advisers, Llc0.00%19,514$1,971$17,621+$15,650+794.02%
Goldman Sachs Group Inc0.00%16,064$1,629$14,506+$12,877+790.47%
Belvedere Trading Llc0.00%13,080$1,321$11,811+$10,490+794.11%
Alpha Zero Llc0.00%13,000$1,318$11,739+$10,421+790.67%
Mariner, Llc0.00%12,673$1,285$11,444+$10,159+790.56%
Nixon Peabody Trust Co0.00%11,126$1,128$10,047+$8,919+790.67%
Lpl Financial Llc0.00%10,933$1,109$9,872+$8,763+790.22%
Coyle Financial Counsel Llc0.00%10,509$1,066$9,490+$8,424+790.21%
Tower Research Capital Llc (Trc)0.00%8,740$886$7,892+$7,006+790.77%
Acadian Asset Management Llc0.00%1,750,862$176$1,581,028+$1,580,852+898211.58%
Morgan Stanley0.00%834$84$753+$669+796.55%
Ubs Group Ag0.00%556$56$502+$446+796.55%
Osaic Holdings, Inc.0.00%550$55$497+$442+803.00%
Hurley Capital, Llc0.00%121$12$109+$97+810.52%
Jones Financial Companies Lllp0.00%133$12$120+$108+900.83%
Westside Investment Management, Inc.0.00%75$8$68+$60+746.56%
Cambridge Investment Research Advisors, Inc.0.00%15,200$2$13,726+$13,724+686180.00%
Bnp Paribas Financial Markets0.00%8$1$7+$6+622.40%

Frequently asked questions about QNCX

  • Who owns the most QNCX stock?

    The largest holders of QNCX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for QUINCE THERAPEUTICS INC (QNCX).

  • Is QNCX widely held by superinvestors?

    Many widely followed stocks like QNCX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly QNCX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.